Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 8/20 | 0.48 |
| ▸ | MTTP | P55157 | 3/20 | 0.48 |
| ▸ | FPR1 | P21462 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | KLRK1 | P26718 | 1/20 | 0.41 |
| ▸ | MICA | Q29983 | 1/20 | 0.41 |
| ▸ | RAET1L | Q5VY80 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21528807 | 1.00 | FPR2 (0.48) | FPR2MTTPFPR1MEN1HPGD | |
| SCHEMBL21529031 | 0.88 | MTTP (0.49) | MTTPTSHRP2RX7MMP1MMP3 | |
| SCHEMBL21529162 | 0.88 | MTTP (0.49) | MTTPTSHRP2RX7MMP1MMP3 | |
| SCHEMBL16289262 | 0.81 | FPR2 (0.53) | FPR2FPR1MEN1HPGDTSHR | |
| SCHEMBL16289260 | 0.81 | FPR2 (0.53) | FPR2FPR1MEN1HPGDTSHR | |
| SCHEMBL4205338 | 0.80 | FPR2 (0.52) | FPR2FPR1MEN1TSHRKMT2A | |
| SCHEMBL5552607 | 0.80 | FPR2 (0.52) | FPR2FPR1MEN1TSHRKMT2A | |
| SCHEMBL4214360 | 0.80 | FPR2 (0.52) | FPR2FPR1MEN1TSHRKMT2A | |
| Hydrochloric Acid SCHEMBL4725522 | 0.79 | FPR2 (0.51) | FPR2FPR1MEN1KMT2AKDM4E | |
| SCHEMBL13791833 | 0.77 | ECE1 (0.42) | FPR2MTTPFPR1CYP3A4P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11384060-B2 | Amide compounds and use thereof | ALPHALA CO., LTD. (TW) | 2022-07-12 | — | — | US | disclosed |
| US-20190337915-A1 | AMIDE COMPOUNDS AND USE THEREOF | ALPHALA CO., LTD. (TW) | 2019-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190337915-A1 | AMIDE COMPOUNDS AND USE THEREOF | GLP1R, IAPP, GPR119 | FPR2 1878/4885MTTP 419/4885FPR1 685/4885 |
| US-11384060-B2 | Amide compounds and use thereof | GLP1R, IAPP, GPR119 | FPR2 1878/4885MTTP 419/4885FPR1 685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.